ArticleClinical case reports2026
A Case of Drug-Induced Pancreatitis.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-induced pancreatitis (DIP) is a rare but important cause of acute abdominal pain, and ciprofloxacin-associated cases are exceptionally uncommon. We report a 35-year-old woman with no significant medical history who developed severe epigastric pain radiating to the back, accompanied by nausea and vomiting, 3 days after initiating self-prescribed ciprofloxacin for diarrhea. Laboratory tests revealed markedly elevated serum amylase and lipase, and contrast-enhanced CT confirmed acute interstitial pancreatitis. Common causes including gallstones, alcohol use, hypertriglyceridemia, hypercalcemia, and viral hepatitis were excluded. Ciprofloxacin was discontinued, and the patient was managed with intravenous fluids, bowel rest, and analgesia, leading to rapid clinical and biochemical improvement within 4 days. Given the temporal relationship, exclusion of alternative etiologies, and supportive causality assessments (Naranjo Adverse Drug Reaction Probability Scale & Badalov Classification), ciprofloxacin was considered the probable cause. This case underscores the importance of considering DIP in patients presenting with new-onset abdominal pain during fluoroquinolone therapy, as prompt drug withdrawal and supportive care can result in swift recovery and prevent complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.